Magellan Health Inc (MGLN) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Magellan Health inc   (NASDAQ: MGLN)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Magellan Health Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Magellan Health Inc's ROI in the third quarter of 2021?
Magellan Health inc achieved a return on average invested assets (ROI) of 11.7 % in its third quarter of 2021, this is above MGLN's average return on investment of 5.86%.
Magellan Health Inc s investments during the 12 months ending in the third quarter of 2021 are valued at $2 billion

ROI fell compared to the second quarter of 2021, despite the net income growth of % from the second quarter of 2021.

Within the Healthcare sector 97 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 727 to 866.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 15.88 % 14.22 % 12.03 % 8.23 % 4.76 %
Y / Y Net Income Change TTM 125.42 % 114.28 % 552.01 % 813.41 % 529.81 %
Investment (TTM) in Millions 2,579 2,571 2,561 2,615 2,280
Return On Investment (TTM) 11.7 % 12.28 % 16.15 % 16.41 % 6.01 %
MGLN's Overall Ranking # 866 # 727 # 123 # 316 # 991
Seq. Investment Change TTM 2.98 % 3.27 % 4.18 % 4.59 % 1.5 %
Seq. Net Income Change TTM -1.86 % -21.48 % 2.5 % 185.35 % -6.7 %
Net Income (TTM) in Millions 302 308 392 382 134

MGLN Company Profile >> Back to MGLN Roi Comparisons >> See Annual MGLN Return On Investment



Return On Investment MGLN's Ranking
Within: No.
Industry # 7
Sector # 98
Overall # 866

Return On Investment Statistics
High Average Low
16.36 %
5.86 %
0.34 %
(Dec 31 2020)   (Sep 30 2019)







Financial Statements
Magellan Health Inc's III. Quarter Investments $ 2,579 Millions MGLN's Balance sheet
Magellan Health Inc's III. Quarter Income $ 6 Millions Quarterly MGLN's Income Statement
MGLN's Income by Division See MGLN's Income by Division


MGLN Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 2,615 2,165 2,069 2,053 1,351
Y / Y Investment Growth 20.79 % 4.64 % 0.8 % 51.95 % 0.45 %
Net Income in Millions 382 56 24 110 76
Y / Y Net Income Growth 583.94 % 131.18 % -78.05 % 45.33 % 164.01 %
Annual Return On Investment 14.62 % 2.58 % 1.17 % 5.37 % 5.61 %


Annual Roi Comment
In the fiscal year 2020 ROI improved to 14.62 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MGLN's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MGLN's Competitors
Subscribers only: Roi for Magellan Health Inc's Suppliers
Subscribers only: Return On Investment for MGLN's Customers

Other Ratios
MGLN's Roa MGLN's Inventory Turnover Ratio MGLN's Growth Rates MGLN's Dividend Statistics
MGLN's Profitability Ratios MGLN's Asset Turnover Ratio MGLN's Dividend Growth
MGLN's Roe MGLN's Valuation Ratios MGLN's Financial Strength Ratios MGLN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI
Carisma Therapeutics Inc   32.15 %
Mettler toledo International Inc   32.10 %
Nrc Health  32.05 %
Lifevantage Corp  28.43 %
Bionexus Gene Lab Corp   28.01 %
Neurocrine Biosciences Inc   26.67 %
Hologic Inc  26.27 %
Chemed Corporation  26.20 %
West Pharmaceutical Services Inc   25.54 %
Tivity Health Inc   25.10 %
Elite Pharmaceuticals Inc   24.48 %
Encision Inc   23.71 %
Dyadic International Inc   23.56 %
Vaso Corporation  23.38 %
Collegium Pharmaceutical Inc   23.26 %
Edwards Lifesciences Corporation  22.41 %
Sana Biotechnology Inc   22.32 %
Catalyst Pharmaceuticals Inc   22.25 %
Organogenesis Holdings Inc   22.02 %
Vertex Pharmaceuticals Inc  21.16 %
Corcept Therapeutics Inc  20.28 %
Align Technology inc   20.16 %
Waters Corporation  18.90 %
Quest Diagnostics Inc  18.24 %
Amedisys Inc  18.07 %
Meridian Bioscience Inc   17.93 %
Lftd Partners Inc   17.65 %
Procyon Corporation  17.44 %
Eli Lilly And Company  17.40 %
Crispr Therapeutics Ag  17.16 %

Date modified: 2026-09-08T15:10:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.